首页 | 本学科首页   官方微博 | 高级检索  
检索        

乌司他丁持续静脉泵入联合CRRT治疗MODS的临床研究
引用本文:亢宏山,白艳,刘亚晶,王晶,刘淑红,王会青,马珍,丁方,崔朝勃.乌司他丁持续静脉泵入联合CRRT治疗MODS的临床研究[J].重庆医学,2017,46(11).
作者姓名:亢宏山  白艳  刘亚晶  王晶  刘淑红  王会青  马珍  丁方  崔朝勃
作者单位:1. 河北省衡水市哈励逊国际和平医院重症医学科 053000;2. 河北省衡水市妇儿医院产一科 053000
基金项目:河北省衡水市科研与发展计划项目
摘    要:目的 评价乌司他丁联合连续性肾替代疗法(CRRT)治疗多器官功能障碍综合征(MODS)的临床疗效.方法 选取2013年7月至2015年7月河北省衡水市哈励逊国际和平医院重症医学科收治的68例MODS患者,分成对照组(23例)、CRRT组(22例)、联合组(23例).记录治疗前,治疗72 h、1周后的急性生理学及慢性健康状况评分系统(APACHE-Ⅱ)评分、序贯性器官衰竭评估(SOFA)评分、炎症指标的变化情况及炎症介质水平,比较入住ICU的病死率.结果 治疗72 h、1周后,CRRT组及联合组患者白细胞介素(IL)-10、IL-6、肿瘤坏死因子α(TNF-α)、白细胞计数(WBC)、降钙素原(PCT)、C反应蛋白(CRP)水平明显优于对照组(P<0.05),而联合组优于CRRT组(P<0.05).治疗72 h、1周后,CRRT组及联合组氧合指数、乳酸、丙氨酸氨基转移酶(ALT)较对照组明显改善(P<0.05),联合组改善更显著(P<0.05).在治疗1周后,CRRT组及联合组病死率明显低于对照组(P<0.05),而CRRT组和联合组比较差异无统计学意义(P>0.05).结论 乌司他丁联合CRRT是治疗MODS的有效方法.

关 键 词:乌司他丁  持续床旁血液净化治疗  多器官功能衰竭

Clinical study of ulinastatin combined with CRRT in the treatment of multiple organ dysfunction syndrome
Kang Hongshan,Bai Yan,Liu Yajing,Wang Jing,Liu Shuhong,Wang Huiqing,Ma Zhen,Ding Fang,Cui Zhaobo.Clinical study of ulinastatin combined with CRRT in the treatment of multiple organ dysfunction syndrome[J].Chongqing Medical Journal,2017,46(11).
Authors:Kang Hongshan  Bai Yan  Liu Yajing  Wang Jing  Liu Shuhong  Wang Huiqing  Ma Zhen  Ding Fang  Cui Zhaobo
Abstract:Objective To evaluate the clinical curative effect of ulinastatin combined with CRRT in the treatment of multiple organ dysfunction syndrome(MODS).Methods Sixty eight patients with MODS who were admitted to ICU from July 2013 to July 2015 were randomly divided into three groups:control group,CRRT group,combined group;Patients' APACHE Ⅱ,SOFA scores level of inflammatory markers were recorded before treatment and after treatment of 72 hours and 7 days.The mortality of the three groups in ICU were compared.Results After 72 hours and a week of treatment,the level of IL-10,IL-6,TNF-α,WBC、PCT、CRP in CRRT group and combined group were significantly better than that of control group(P<0.05),and combined group were significantly better than that of CRRT group.Compared with the control group,the oxygen index,lactic acid,ALT significantly im proved in CRRT group and combined group were better than control group,after 72 hours and a week of treatment(P<0.05),and the cornbined group was the most obvious.After a week of treatment,the mortality rate of CRRT group and combined group was significantly better than the control group (P<0.05),while there was no statistical differences between CRRT group and combined group(P>0.05).Conclusion Ulinastatin combined with CRRT is an effective method for the treatment of MODS.
Keywords:ulinastatin  continuous renal replacement therapy  multiple organ failure
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号